Marketing

Evonik hikes up pharma excipient prices

Evonik hikes up pharma excipient prices

By Dan Stanton

Increasing QbD needs and a range of technical service centres have driven up the prices of Evonik’s drug delivery excipient portfolio, the company says.

FDA Finalizes cGMP Rule for Drug-Device Combo Makers

FDA Finalizes cGMP Rule for Drug-Device Combo Makers

By Zachary Brennan

The US Food and Drug Administration (FDA) has finalized a rule clarifying current good manufacturing practice (cGMP) requirements for single-entity and co-packaged drug-device combination products with few changes to its proposed rule from 2009.